AngioDynamics Inc
ANGO8.670USD
+0.110+1.29%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
355.42MCap. mercado
PérdidaP/E TTM
Más Datos de AngioDynamics Inc Compañía
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Información de la empresa
Símbolo de cotizaciónANGO
Nombre de la empresaAngioDynamics Inc
Fecha de salida a bolsaMay 27, 2004
Director ejecutivoMr. James C. Clemmer
Número de empleados675
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 27
Dirección14 Plaza Drive
CiudadLATHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal12110
Teléfono15187981215
Sitio Webhttps://www.angiodynamics.com/
Símbolo de cotizaciónANGO
Fecha de salida a bolsaMay 27, 2004
Director ejecutivoMr. James C. Clemmer
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
342.85K
+31.96%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
+11.83%
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
138.76K
+23.88%
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
+15.78%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ms. Lorinda A. Burgess
Ms. Lorinda A. Burgess
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
342.85K
+31.96%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
+11.83%
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
138.76K
+23.88%
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
+15.78%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
61.34M
85.19%
International
10.66M
14.81%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
7.53%
Systematic Financial Management, L.P.
6.15%
The Vanguard Group, Inc.
6.13%
Millennium Management LLC
5.28%
Divisadero Street Capital Management, LP
5.26%
Other
69.65%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
7.53%
Systematic Financial Management, L.P.
6.15%
The Vanguard Group, Inc.
6.13%
Millennium Management LLC
5.28%
Divisadero Street Capital Management, LP
5.26%
Other
69.65%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
35.57%
Investment Advisor/Hedge Fund
31.53%
Hedge Fund
20.99%
Individual Investor
6.84%
Research Firm
3.21%
Pension Fund
1.56%
Private Equity
0.88%
Bank and Trust
0.25%
Insurance Company
0.03%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
376
39.73M
97.80%
-5.84M
2025Q1
387
38.84M
95.70%
-6.48M
2024Q4
375
36.32M
89.71%
-5.96M
2024Q3
384
35.71M
87.94%
-11.00M
2024Q2
382
35.41M
88.44%
-13.81M
2024Q1
384
38.17M
95.80%
-10.29M
2023Q4
394
39.11M
98.18%
-8.70M
2023Q3
380
38.76M
97.39%
-7.29M
2023Q2
379
38.85M
99.01%
-7.43M
2023Q1
376
39.36M
100.34%
-6.61M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
3.06M
7.53%
-175.89K
-5.44%
Mar 31, 2025
Systematic Financial Management, L.P.
2.50M
6.15%
-23.78K
-0.94%
Mar 31, 2025
The Vanguard Group, Inc.
2.49M
6.14%
+199.94K
+8.72%
Mar 31, 2025
Millennium Management LLC
1.24M
3.05%
-923.00K
-42.68%
Mar 31, 2025
Divisadero Street Capital Management, LP
2.14M
5.26%
+1.18M
+122.60%
Jun 02, 2025
Armistice Capital LLC
2.09M
5.16%
+1.22M
+140.14%
Mar 31, 2025
Segall Bryant & Hamill, LLC
1.38M
3.41%
-30.72K
-2.17%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.17M
2.87%
-323.10K
-21.70%
Mar 31, 2025
Nuveen LLC
1.15M
2.83%
-145.78K
-11.26%
Mar 31, 2025
Clemmer James C
929.61K
2.29%
+20.00K
+2.20%
Oct 07, 2024
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
0.52%
Invesco NASDAQ Future Gen 200 ETF
0.44%
Vanguard US Multifactor ETF
0.14%
Vanguard US Momentum Factor ETF
0.12%
iShares Micro-Cap ETF
0.09%
Vanguard US Quality Factor ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
Invesco Russell 2000 Dynamic Multifactor ETF
0.06%
Avantis US Small Cap Equity ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.04%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción0.52%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.44%
Vanguard US Multifactor ETF
Proporción0.14%
Vanguard US Momentum Factor ETF
Proporción0.12%
iShares Micro-Cap ETF
Proporción0.09%
Vanguard US Quality Factor ETF
Proporción0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.07%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.06%
Avantis US Small Cap Equity ETF
Proporción0.05%
Fidelity Enhanced Small Cap ETF
Proporción0.04%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
